Forum:The Void Within
From Destinypedia, the Destiny wiki
Forums: Index → Fan Fiction → The Void Within |
This article has new content coming soon from The Void Within and may not be complete, confirmed, or correct. Please update it as soon as any relevant and accurate material is available. Editors must cite sources for all contributions to this article. Edits that do not follow this standard will be reverted without notice. For more information, see the Citation policy.
The Void Within | |
---|---|
Developer(s): |
|
Publisher(s): |
|
Platform(s): |
Xbox One |
Release date(s): |
September 10th, 2024 |
Genre(s): |
|
Rating(s): |
ESRB: Teen (T) for Blood, Drug Reference, Language and Violence |
The Void Within is the ninth and final expansion of Destiny 2, the twelfth and final expansion of the Destiny franchise, and the third expansion of the Redux Trilogy.
Description
EVERYTHING HAS CHANGED.
As the City still recovers from Kirito's onslaught, a new threat emerges. Beneath Earth's crust, a cult of Heretical Warlocks have opened a massive Gateway, calling forth eldritch abominations from a realm beyond our own, seeking to reawaken Kothal from their slumber and bring the world under the will of The Void. Return to the Ascendant Plane and hunt down the Sanctum Heralds so that you can bring an end to their diabolical attack on the Traveler.
Overview
Appearances
- This article is a stub. You can help Destinypedia by expanding it.
Characters
Organizations
Locations
|
Events
Weapons and Armor
|
Features
- New Missions, & Quests
- New Destinations & Dungeons
- New Subclasses
- New Weapons and Gear to Earn
- An All New Raid
- New gear to uncover
- Xbox Exclusive Contents: Exotic Kinetic Time's End Fusion Rifle and Legendary Voidgazer Pursuit Sparrow
- And More
Gameplay Updates
Guardian Sublasses & Changes
Loot
- New Gear to unlock
- New Exotics to earn
Locations
Missions
Strikes
Dungeons
Raids
Crucible
Gambit
Adventures
Lost Sectors
Accompanying Season
- Season 28
Trivia
- This is the first expansion to feature Guardians as primary antagonists.